Web14 de ago. de 2003 · Careful monitoring, an AST and ALT less than 2-3 times the ULN, a CPK less than 10 times the ULN, and a normal serum creatine should not prohibit statin or combination therapy. Ongoing LFTs Web2. Statin therapy has shown clear benefits and is recommended in four major groups of patients (strong evidence): 1,2. Patient Group Recommended Intensity of Statin Treatment Clinical ASCVD* Age ≤ 75 years with no statin-related safety concerns † a High Age > 75 years or with statin-related safety concerns Moderate . LDL . ≥ 190 mg/dL ...
National Center for Biotechnology Information
Web4 de mar. de 2024 · Statin is highly recommended for dyslipidemia to prevent atherosclerosis-related cardiovascular diseases and death. The aim of this study was to compare the efficacies and safeties of low/moderate-intensity statin plus ezetimibe combination therapy vs. high-intensity statin monotherapy. Meta-analysis was … Web26 de out. de 2024 · The most common myopathy associated with statin use, myalgia, only occurs in about 1 out of every 1,000 patients taking statins. The chance of experiencing … how drive safely you
Liver tests are irrelevant when prescribing statins - The Lancet
Web6 de jan. de 2024 · Many diseases and conditions can contribute to elevated liver enzymes. Your doctor determines the cause by reviewing your medications, your signs … Web17 de mar. de 2024 · In those with multiple ASCVD risk factors, consider high-intensity statin with aim of lowering LDL-C by 50% or more. Age >75 years, clinical assessment and risk discussion. Age 40-75 years and LDL-C ≥70 mg/dl and <190 mg/dl without diabetes, use the risk estimator that best fits the patient and risk-enhancing factors to decide … Web14 de jul. de 2024 · High levels of alanine transaminase (ALT) can indicate a liver problem but do not necessarily mean you have a health condition. Very elevated levels of ALT … how drive the car